Annual CFO
-$1.36 M
+$3.85 M+73.88%
September 1, 2024
Summary
- As of February 7, 2025, DRUG annual cash flow from operations is -$1.36 million, with the most recent change of +$3.85 million (+73.88%) on September 1, 2024.
- During the last 3 years, DRUG annual CFO has risen by +$4.43 million (+76.51%).
- DRUG annual CFO is now -533.60% below its all-time high of -$214.60 thousand, reached on September 30, 2020.
Performance
DRUG Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$346.30 K
-$539.30 K-279.43%
September 1, 2024
Summary
- As of February 7, 2025, DRUG quarterly cash flow from operations is -$346.30 thousand, with the most recent change of -$539.30 thousand (-279.43%) on September 1, 2024.
- Over the past year, DRUG quarterly CFO has increased by +$257.60 thousand (+42.66%).
- DRUG quarterly CFO is now -279.43% below its all-time high of $193.00 thousand, reached on June 1, 2024.
Performance
DRUG Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$1.36 M
+$526.90 K+27.93%
September 1, 2024
Summary
- As of February 7, 2025, DRUG TTM cash flow from operations is -$1.36 million, with the most recent change of +$526.90 thousand (+27.93%) on September 1, 2024.
- Over the past year, DRUG TTM CFO has increased by +$2.49 million (+64.66%).
- DRUG TTM CFO is now -2908.41% below its all-time high of -$45.20 thousand, reached on December 31, 2019.
Performance
DRUG TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
DRUG Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +73.9% | +42.7% | +64.7% |
| 3 y3 years | +76.5% | +42.7% | +64.7% |
| 5 y5 years | -533.6% | +42.7% | +64.7% |
DRUG Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +87.2% | -279.4% | +91.2% | at high | +87.7% |
| 5 y | 5-year | -533.6% | +87.2% | -279.4% | +91.2% | -2908.4% | +87.7% |
| alltime | all time | -533.6% | +87.2% | -279.4% | +91.2% | -2908.4% | +87.7% |
Bright Minds Biosciences Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$1.36 M(-73.9%) | -$346.30 K(-279.4%) | -$1.36 M(-27.9%) |
| Jun 2024 | - | $193.00 K(-132.0%) | -$1.89 M(-43.3%) |
| Mar 2024 | - | -$602.60 K(-0.2%) | -$3.32 M(-13.6%) |
| Dec 2023 | - | -$603.90 K(-30.8%) | -$3.85 M(-26.1%) |
| Sep 2023 | -$5.20 M(-51.1%) | -$873.20 K(-29.9%) | -$5.20 M(-13.3%) |
| Jun 2023 | - | -$1.25 M(+10.6%) | -$6.00 M(-13.5%) |
| Mar 2023 | - | -$1.13 M(-42.6%) | -$6.94 M(-20.0%) |
| Dec 2022 | - | -$1.96 M(+17.5%) | -$8.67 M(-18.5%) |
| Sep 2022 | -$10.64 M | -$1.67 M(-23.6%) | -$10.64 M(-1.0%) |
| Jun 2022 | - | -$2.18 M(-23.5%) | -$10.74 M(-2.6%) |
| Mar 2022 | - | -$2.86 M(-27.3%) | -$11.03 M(+18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | - | -$3.93 M(+121.3%) | -$9.30 M(+60.6%) |
| Sep 2021 | -$5.79 M(+2597.7%) | - | - |
| Sep 2021 | - | -$1.78 M(-28.1%) | -$5.79 M(+38.7%) |
| Jun 2021 | - | -$2.47 M(+120.1%) | -$4.17 M(+147.5%) |
| Mar 2021 | - | -$1.12 M(+166.2%) | -$1.69 M(+185.3%) |
| Dec 2020 | - | -$421.70 K(+166.1%) | -$591.00 K(+175.5%) |
| Sep 2020 | -$214.60 K | - | - |
| Sep 2020 | - | -$158.50 K(-1049.1%) | -$214.50 K(+283.0%) |
| Jun 2020 | - | $16.70 K(-160.7%) | -$56.00 K(-23.0%) |
| Mar 2020 | - | -$27.50 K(-39.2%) | -$72.70 K(+60.8%) |
| Dec 2019 | - | -$45.20 K | -$45.20 K |
FAQ
- What is Bright Minds Biosciences annual cash flow from operations?
- What is the all time high annual CFO for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual CFO year-on-year change?
- What is Bright Minds Biosciences quarterly cash flow from operations?
- What is the all time high quarterly CFO for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly CFO year-on-year change?
- What is Bright Minds Biosciences TTM cash flow from operations?
- What is the all time high TTM CFO for Bright Minds Biosciences?
- What is Bright Minds Biosciences TTM CFO year-on-year change?
What is Bright Minds Biosciences annual cash flow from operations?
The current annual CFO of DRUG is -$1.36 M
What is the all time high annual CFO for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual cash flow from operations is -$214.60 K
What is Bright Minds Biosciences annual CFO year-on-year change?
Over the past year, DRUG annual cash flow from operations has changed by +$3.85 M (+73.88%)
What is Bright Minds Biosciences quarterly cash flow from operations?
The current quarterly CFO of DRUG is -$346.30 K
What is the all time high quarterly CFO for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly cash flow from operations is $193.00 K
What is Bright Minds Biosciences quarterly CFO year-on-year change?
Over the past year, DRUG quarterly cash flow from operations has changed by +$257.60 K (+42.66%)
What is Bright Minds Biosciences TTM cash flow from operations?
The current TTM CFO of DRUG is -$1.36 M
What is the all time high TTM CFO for Bright Minds Biosciences?
Bright Minds Biosciences all-time high TTM cash flow from operations is -$45.20 K
What is Bright Minds Biosciences TTM CFO year-on-year change?
Over the past year, DRUG TTM cash flow from operations has changed by +$2.49 M (+64.66%)